{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:23:40Z","timestamp":1789622620368,"version":"build-2803163510"},"reference-count":103,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Background: The COVID-19 pandemic period revolutionized daily clinical practice. Several strategies were adopted by clinicians to avoid reducing treatment for diseases without the risk of spreading the infection. Among the adopted strategies, telemedicine played a key role. In this scenario, several tools were used, including e-mails, phone calls, video calls, support groups, and messages. Fortunately, the COVID-19 pandemic period seems to be at an end. However, the use of teledermatology appears to be an excellent strategy for the future as well. Indeed, several patients may benefit from teledermatology. Objective: In this manuscript, we aim to investigate the use of telemedicine in the dermatological field to point out how this tool may become the mainstay of future medicine. Only the use of teledermatology with common inflammatory skin conditions have been reported herein. Materials and Methods: Investigated manuscripts included metanalyses, reviews, letters to the editor, real-life studies, case series, and reports. Manuscripts were identified, screened, and extracted for relevant data following the PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines. Results: A total of 121 records were identified from the analyzed databases. However, only 110 articles were assessed for eligibility. Finally, 92 articles were selected at the end of the literature research for our review. Conclusions: Teledermatology should be considered as a viable option for the dermatologist for the future. We believe that the pandemic has strengthened this service, and this will allow for ever better development in the future. Guidelines regarding the use of teledermatology are required as well as additional improvements for the future.<\/jats:p>","DOI":"10.3390\/life13041037","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T01:36:45Z","timestamp":1681781805000},"page":"1037","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future?"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2523-050X","authenticated-orcid":false,"given":"Fabrizio","family":"Martora","sequence":"first","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Fabbrocini","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1803-2046","authenticated-orcid":false,"given":"Matteo","family":"Megna","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Scalvenzi","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Battista","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Villani","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5940-0592","authenticated-orcid":false,"given":"Luca","family":"Potestio","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1089\/tmj.2011.0103","article-title":"The Taxonomy of Telemedicine","volume":"17","author":"Bashshur","year":"2011","journal-title":"Telemed. e-Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/idoj.IDOJ_241_19","article-title":"Teledermatology and its current perspective","volume":"11","author":"Pasquali","year":"2020","journal-title":"Indian Dermatol. Online J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.2147\/CCID.S377029","article-title":"The Role of Teledermatology during the COVID-19 Pandemic: A Narrative Review","volume":"15","author":"Ruggiero","year":"2022","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/ced.15286","article-title":"Video and telephone teledermatology consultations during COVID-19 in comparison: Patient satisfaction, doubts and concerns","volume":"47","author":"Ruggiero","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/1346-8138.15812","article-title":"Teledermatology in times of COVID-19","volume":"48","author":"Stadler","year":"2021","journal-title":"J. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1111\/ced.15306","article-title":"Management of patients with hidradenitis suppurativa during COVID-19 vaccination: An experience from southern Italy. Comment on: \u2018Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa\u2019","volume":"47","author":"Martora","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jocd.15477","article-title":"COVID-19 and cutaneous manifestations: A review of the published literature","volume":"22","author":"Martora","year":"2023","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s40257-022-00675-2","article-title":"Cutaneous Manifestations of SARS-CoV-2 Infection","volume":"23","author":"Huynh","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/wound.2020.1309","article-title":"Cutaneous Manifestations of COVID-19: A Systematic Review","volume":"10","author":"Singh","year":"2021","journal-title":"Adv. Wound Care"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e863","DOI":"10.1111\/jdv.18341","article-title":"Reply to \u2018Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study\u2019 by Bawane J et al","volume":"36","author":"Potestio","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Campanati, A., Martina, E., and Offidani, A. (2022). The Challenge Arising from New Knowledge about Immune and Inflammatory Skin Diseases: Where We Are Today and Where We Are Going. Biomedicines, 10.","DOI":"10.3390\/biomedicines10050950"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e15374","DOI":"10.1111\/dth.15374","article-title":"New-onset lichen planus arising after COVID-19 vaccination","volume":"35","author":"Zagaria","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s13555-022-00689-y","article-title":"A Case of New-Onset Lichen Planus after COVID-19 Vaccination","volume":"12","author":"Picone","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e14848","DOI":"10.1111\/dth.14848","article-title":"COVID-19 related masks increase severity of both acne (maskne) and rosacea (mask rosacea): Multi-center, real-life, telemedical, and observational prospective study","volume":"34","author":"Damiani","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1111\/jdv.18248","article-title":"Maskne prevalence and risk factors during the COVID-19 pandemic","volume":"36","author":"Villani","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2147\/CCID.S388245","article-title":"Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature","volume":"15","author":"Martora","year":"2022","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"qt0j5150df","DOI":"10.5070\/D32610050454","article-title":"Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and acne\/rosacea during the COVID-19 pandemic","volume":"26","author":"Yim","year":"2020","journal-title":"Dermatol. Online J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1111\/ced.15336","article-title":"The impact of COVID-19 infection on patients with psoriasis treated with biologics: An Italian experience","volume":"47","author":"Ruggiero","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e15030","DOI":"10.1111\/dth.15030","article-title":"Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?","volume":"34","author":"Megna","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1080\/14712598.2022.2089020","article-title":"Treating psoriasis in the elderly: Biologics and small molecules","volume":"22","author":"Megna","year":"2022","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2147\/CCID.S364640","article-title":"Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence","volume":"15","author":"Ruggiero","year":"2022","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e15102","DOI":"10.1111\/dth.15102","article-title":"Onset of vitiligo in a psoriasis patient on ixekizumab","volume":"34","author":"Marasca","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/jocd.14938","article-title":"Teledermatology: A useful tool also after COVID-19 era?","volume":"21","author":"Megna","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_24","first-page":"465","article-title":"Assessing Patient Satisfaction with Teledermatology Implementation during the COVID-19 Pandemic","volume":"290","author":"Hamad","year":"2022","journal-title":"Stud. Health Technol. Inform."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.36849\/JDD.5714","article-title":"Patient Perceptions and Satisfaction with Teledermatology during the COVID-19 Pandemic: A Survey-Based Study","volume":"20","author":"Yeroushalmi","year":"2021","journal-title":"J. Drugs Dermatol."},{"key":"ref_26","first-page":"103","article-title":"Teledermatology management of difficult-to-treat dermatoses in the Faroe Islands","volume":"28","author":"Andersen","year":"2019","journal-title":"Acta Dermatovenerol. Alp. Pannonica Adriat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00403-020-02145-3","article-title":"Teledermatology: Current indications and considerations for future use","volume":"313","author":"Beer","year":"2021","journal-title":"Arch. Dermatol. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jaad.2011.05.047","article-title":"Patient-centered online management of psoriasis: A randomized controlled equivalency trial","volume":"66","author":"Chambers","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1111\/ced.15395","article-title":"Immune response to COVID-19 mRNA vaccination in patients with psoriasis undergoing treatment with biologics","volume":"47","author":"Megna","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1440-0960.2011.00852.x","article-title":"Pilot study on the acceptance of mobile teledermatology for the home monitoring of high-need patients with psoriasis","volume":"53","author":"Schwantzer","year":"2012","journal-title":"Australas. J. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.clindermatol.2021.05.016","article-title":"Moving forward with teledermatology: Operational challenges of a hybrid in-person and virtual practice","volume":"39","author":"Julie","year":"2021","journal-title":"Clin. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10067-013-2175-9","article-title":"What patients think about E-health: Patients\u2019 perspective on internet-based cognitive behavioral treatment for patients with rheumatoid arthritis and psoriasis","volume":"32","author":"Ferwerda","year":"2013","journal-title":"Clin. Rheumatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/tmj.2018.0160","article-title":"Access to Dermatological Care with an Innovative Online Model for Psoriasis Management: Results from a Randomized Controlled Trial","volume":"25","author":"Ford","year":"2019","journal-title":"Telemed. e-Health"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e183062","DOI":"10.1001\/jamanetworkopen.2018.3062","article-title":"Effectiveness of Online vs. In-Person Care for Adults with Psoriasis: A Randomized Clinical Trial","volume":"1","author":"Armstrong","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s13555-021-00555-3","article-title":"Preference for Telemedicine versus In-Person Visit among Patients with Psoriasis Receiving Biological Drugs","volume":"11","author":"Gisondi","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jdin.2022.02.001","article-title":"Clinical profile and response to treatment of patients with psoriasis seen via teledermatology during the COVID-19 pandemic in the Philippines","volume":"7","author":"Tinio","year":"2022","journal-title":"JAAD Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jaad.2019.05.089","article-title":"Effects of online care on functional and psychological outcomes in patients with psoriasis: A randomized controlled trial","volume":"88","author":"Young","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e662","DOI":"10.1111\/jdv.16746","article-title":"Teledermatology for acne during COVID-19: High patients\u2019 satisfaction in spite of the emergency","volume":"34","author":"Ruggiero","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e2022036","DOI":"10.5826\/dpc.1201a36","article-title":"Isotretinoin Treatment Practices and Outcomes in Acne Patients during the COVID-19 Pandemic: A Single Center, Retrospective, Comparative Study","volume":"12","author":"Atak","year":"2022","journal-title":"Dermatol. Pr. Concept."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jamadermatol.2017.5141","article-title":"Using Network Oriented Research Assistant (NORA) Technology to Compare Digital Photographic with In-Person Assessment of Acne Vulgaris","volume":"154","author":"Singer","year":"2018","journal-title":"JAMA Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/jdv.12723","article-title":"Mobile teledermatology helping patients control high-need acne: A randomized controlled trial","volume":"29","author":"Quehenberger","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/tmj.2020.0299","article-title":"Utilization of Asynchronous and Synchronous Teledermatology in a Large Health Care System during the COVID-19 Pandemic","volume":"27","author":"Kazi","year":"2021","journal-title":"Telemed. e-Health"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jocd.14606","article-title":"Retrospective study of acne telemedicine and in-person visits at an academic center during the COVID-19 pandemic","volume":"21","author":"Gu","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaad.2022.03.004","article-title":"Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study","volume":"87","author":"Eiris","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jaad.2021.05.008","article-title":"Differences in virtual care utilization for acne by vulnerable populations during the COVID-19 pandemic: A retrospective review","volume":"85","author":"Lee","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/jocd.14805","article-title":"Long-term results of teledermatology for acne patients during COVID-19 pandemic","volume":"21","author":"Villani","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000521712","article-title":"A Case of Pemphigus Vulgaris and Hidradenitis Suppurativa: May Systemic Steroids Be Considered in the Standard Management of Hidradenitis Suppurativa?","volume":"8","author":"Martora","year":"2022","journal-title":"Ski. Appendage Disord."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/ced.14687","article-title":"Remote consultations for patients with hidradenitis suppurativa during the COVID-19 pandemic: A single-centre experience","volume":"46","author":"Patel","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1111\/ijd.15022","article-title":"Remote management of hidradenitis suppurativa in a pandemic era of COVID-19","volume":"59","author":"Kang","year":"2020","journal-title":"Int. J. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/jocd.15292","article-title":"Teledermatology in the management of hidradenitis suppurativa: Should we improve this service?","volume":"22","author":"Ruggiero","year":"2023","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1111\/ced.15291","article-title":"Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: Comment on \u2018Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?\u2019","volume":"47","author":"Martora","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jdcr.2022.03.008","article-title":"Hidradenitis suppurativa flares following COVID-19 vaccination: A case series","volume":"23","author":"Martora","year":"2022","journal-title":"JAAD Case Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jdcr.2022.05.005","article-title":"Response to Martora et al\u2019s \u201cHidradenitis suppurativa flares following COVID-19 vaccination: A case series\u201d","volume":"25","author":"Alexander","year":"2022","journal-title":"JAAD Case Rep."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Ruggiero, A., Martora, F., Picone, V., Marano, L., Fabbrocini, G., and Marasca, C. (2022). Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020455"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000506074","article-title":"Paradoxical Hidradenitis Suppurativa in Patients Receiving TNF-\u03b1 Inhibitors: Case Series, Systematic Review, and Case Meta-Analysis","volume":"236","year":"2020","journal-title":"Dermatology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2147\/CCID.S391356","article-title":"Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience","volume":"16","author":"Martora","year":"2023","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/jamadermatol.2021.4805","article-title":"Drug Survival of Biologics in Patients with Hidradenitis Suppurativa","volume":"158","author":"Ring","year":"2022","journal-title":"JAMA Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e39803","DOI":"10.1371\/journal.pone.0039803","article-title":"Investigating International Time Trends in the Incidence and Prevalence of Atopic Eczema 1990\u20132010: A Systematic Review of Epidemiological Studies","volume":"7","author":"Deckers","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/jdv.18137","article-title":"Rapid improvement in pruritus in atopic dermatitis patients treated with upadacitinib: A real-life experience","volume":"36","author":"Napolitano","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e15346","DOI":"10.1111\/dth.15346","article-title":"Upadacitinib improved alopecia areata in a patient with atopic dermatitis: A case report","volume":"35","author":"Cantelli","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra2023911","article-title":"Atopic Dermatitis","volume":"384","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1016\/j.jaad.2020.06.015","article-title":"Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic","volume":"83","author":"Kearns","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e15120","DOI":"10.1111\/dth.15120","article-title":"Dupilumab effectiveness for the treatment of patients with concomitant atopic dermatitis and chronic rhinosinusitis with nasal polyposis","volume":"34","author":"Napolitano","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1080\/09546634.2022.2102121","article-title":"Dupilumab for the treatment of adult atopic dermatitis in special populations","volume":"33","author":"Patruno","year":"2022","journal-title":"J. Dermatol. Treat."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Napolitano, M., Fabbrocini, G., Martora, F., Picone, V., Morelli, P., and Patruno, C. (2021). Role of Aryl Hydrocarbon Receptor Activation in Inflammatory Chronic Skin Diseases. Cells, 10.","DOI":"10.3390\/cells10123559"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/all.13953","article-title":"The role of mobile health technologies in allergy care: An EAACI position paper","volume":"75","author":"Matricardi","year":"2020","journal-title":"Allergy"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Marasca, C., Annunziata, M.C., Camela, E., Di Guida, A., Fornaro, L., Megna, M., Napolitano, M., Patruno, C., Potestio, L., and Fabbrocini, G. (2022). Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications. J. Clin. Med., 11.","DOI":"10.3390\/jcm11061511"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jdin.2020.08.002","article-title":"Accuracy and efficiency of telemedicine in atopic dermatitis","volume":"1","author":"Santos","year":"2020","journal-title":"JAAD Int."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/1346-8138.16130","article-title":"Care for children with atopic dermatitis in the Netherlands during the COVID-19 pandemic: Lessons from the first wave and implications for the future","volume":"48","author":"Ragamin","year":"2021","journal-title":"J. Dermatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1111\/jdv.15972","article-title":"Position Statement on Atopic Dermatitis in Sub-Saharan Africa: Current status and roadmap","volume":"33","author":"Takaoka","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11882-021-00989-x","article-title":"Management of Allergic Diseases During COVID-19 Outbreak","volume":"21","author":"Alobid","year":"2021","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1111\/jdv.16411","article-title":"European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis","volume":"34","author":"Wollenberg","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Cheng, Z.J., Qu, H.-Q., Tian, L., Duan, Z., and Hakonarson, H. (2020). COVID-19: Look to the Future, Learn from the Past. Viruses, 12.","DOI":"10.3390\/v12111226"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D3271055615","article-title":"The Impact of teledermatology during the COVID-19 pandemic","volume":"27","author":"Shah","year":"2021","journal-title":"Dermatol. Online J."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e14161","DOI":"10.1111\/dth.14161","article-title":"Mental distress in dermatologists during COVID-19 pandemic: Assessment and risk factors in a global, cross-sectional study","volume":"33","author":"Bhargava","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ad.2020.11.020","article-title":"Direct-to-patient teledermatology during COVID-19 lockdown in a health district in Madrid, Spain: The EVIDE-19 pilot study","volume":"112","author":"Sendagorta","year":"2021","journal-title":"Actas Dermosifiliogr."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jdcr.2020.07.050","article-title":"Inpatient teledermatology in the era of COVID-19 and the importance of the complete skin examination","volume":"6","author":"Deacon","year":"2020","journal-title":"JAAD Case Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00403-020-02170-2","article-title":"Evaluation of patient attitudes towards the technical experience of synchronous teledermatology in the era of COVID-19","volume":"313","author":"Pearlman","year":"2021","journal-title":"Arch. Dermatol. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.5070\/D3274053151","article-title":"Teledermatology after COVID-19: Key challenges ahead","volume":"27","author":"Haque","year":"2021","journal-title":"Dermatol. Online J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/ijd.15272","article-title":"Optimizing teledermatology: Looking beyond the COVID-19 pandemic","volume":"60","author":"Choi","year":"2021","journal-title":"Int. J. Dermatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e15197","DOI":"10.1111\/dth.15197","article-title":"\u201cCovid arm\u201d: Abnormal side effect after Moderna COVID-19 vaccine","volume":"35","author":"Picone","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases","volume":"85","author":"McMahon","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/jmv.27535","article-title":"Can COVID-19 cause atypical forms of pityriasis rosea refractory to conventional therapies?","volume":"94","author":"Martora","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijid.2021.10.055","article-title":"Pityriasis Rosea Shortly after mRNA-1273 COVID-19 Vaccination","volume":"114","author":"Shin","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1002\/jmv.26679","article-title":"Pityriasis rosea and COVID-19","volume":"93","author":"Veraldi","year":"2021","journal-title":"J. Med Virol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e15225","DOI":"10.1111\/dth.15225","article-title":"Pityriasis rosea after Moderna mRNA-1273 vaccine: A case series","volume":"35","author":"Martora","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1111\/jdv.18531","article-title":"Skin reaction after SARS-CoV-2 vaccines Reply to \u2018cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience\u2019","volume":"37","author":"Martora","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e876","DOI":"10.1111\/jdv.18386","article-title":"Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience","volume":"36","author":"Avallone","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1111\/ijd.16236","article-title":"Impact of the COVID-19 pandemic on hospital admissions of patients with rare diseases: An experience of a Southern Italy referral center","volume":"61","author":"Martora","year":"2022","journal-title":"Int. J. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1111\/jdv.18302","article-title":"Reply to \u2018Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2\u2019 by Solimani et al","volume":"36","author":"Martora","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e649","DOI":"10.1111\/jdv.17480","article-title":"Development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2","volume":"35","author":"Solimani","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e976","DOI":"10.1111\/jdv.18398","article-title":"Reply to \u2018development of severe pemphigus vulgaris following SARS-CoV-2 vaccination with BNT162b2\u2019 by Solimani F et al","volume":"36","author":"Falcinelli","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/jocd.15414","article-title":"COVID-19 vaccination and inflammatory skin diseases","volume":"22","author":"Martora","year":"2023","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1111\/jdv.18294","article-title":"Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis","volume":"36","author":"Washrawirul","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e15391","DOI":"10.1111\/dth.15391","article-title":"Cutaneous adverse reactions of COVID-19 vaccines: A systematic review","volume":"35","author":"Qaderi","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/ijd.15809","article-title":"Scabies outbreak during COVID-19: An Italian experience","volume":"60","author":"Potestio","year":"2021","journal-title":"Int. J. Dermatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1111\/jdv.18512","article-title":"Reply to \u2018Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity\u2019 by R. Molinier et al","volume":"37","author":"Ruggiero","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1111\/jdv.17802","article-title":"Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity","volume":"36","author":"Molinier","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1111\/ced.15307","article-title":"The impact of COVID-19 pandemic on nonmelanoma skin cancers: Report of a Southern Italy referral centre","volume":"47","author":"Ruggiero","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1111\/jocd.15331","article-title":"Cutaneous reactions following booster dose of COVID-19 mRNA vaccination: What we should know?","volume":"21","author":"Potestio","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"996288","DOI":"10.3389\/fmed.2022.996288","article-title":"Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic","volume":"9","author":"Maronese","year":"2022","journal-title":"Front. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jocd.15533","article-title":"Cutaneous reactions following COVID-19 vaccination: The evidence says \u201cless fear\u201d","volume":"22","author":"Potestio","year":"2023","journal-title":"J. Cosmet. Dermatol."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/4\/1037\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:17:48Z","timestamp":1760123868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/4\/1037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":103,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["life13041037"],"URL":"https:\/\/doi.org\/10.3390\/life13041037","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,18]]}}}